Possible Mechanisms of Sodium-Dependent Hypertension: Volume Expansion or Vasoconstriction?

References

• Axelrod J. Purification and properties of phenylethanol-amine-N-methyltransferase. J Biol Chem 1962; 237: 1657
   PubMed Web of Science ®Google Scholar
• Black J, Waeber B, Bresnahan MR, Gavras I, Gavras H. Blood pressure response to central and/or peripheral inhibition of phenylethanolamine N-methyltransferase in normotensive and hypertensive rats. Circ Res 1981; 49: 518
   PubMed Web of Science ®Google Scholar
• Brunner HR, Kirshmann JD, Sealey JE, Laragh JH. Hypertension of renal origin: evidence for two different mechanisms. Science 1971; 174: 1344
   PubMed Web of Science ®Google Scholar
• Canessa M, Adragna N, Solomon HS, Connolly TM, Tosteson DC. Increased sodium-lithium counter-transport in red cells of patients with essential hypertension. New Eng J Med 1980; 302: 772
   PubMed Web of Science ®Google Scholar
• deChamplain J, van Ameringen MR. Regulation of blood pressure by sympathetic nerve fibers and adrenal medulla in normotensive and hypertensive rats. Circ Res 1972; 31: 617
   PubMed Web of Science ®Google Scholar
• DiPette DJ, Gavras I, Gavras H. Vasopressin in salt-induced hypertension of experimental renal insufficiency. Presented in the 35th annual conference of the Council for High Blood Pressure Research of the American Heart Association, Cleveland, Ohio, 1981
   Google Scholar
• DiPette DJ, Waeber B, Volicer L, Gavras I, Gavras H. Salt-induced hypertension of chronic renal failure: evidence for a central neurogenic mechanism (Abstract). Presented at the 54th Annual Scientific Sessions of the American Heart Association, Dallas, Texas, 1981
   Google Scholar
• Garay RP, Elghozi J-L, Dagher G, Meyer P. Laboratory distinction between essential and secondary hypertension by measurement of erythrocyte cation fluxes. New Eng J Med 1980; 302: 769
   PubMed Web of Science ®Google Scholar
• Gavras H, Brunner HR, Vaughan ED, Jr., Laragh JH. Angiotensin-sodium interaction in blood pressure maintenance of renal hypertensive and normotensive rats. Science 1973; 180: 1369
   PubMed Web of Science ®Google Scholar
• Gavras H, Brunner HR, Laragh JH, Vaughan ED, Jr., Koss M, Cote LJ, Gavras I. Malignant hypertension resulting from deoxycorticosterone acetate and salt excess. Circ Res 1975; 36: 300
   PubMed Web of Science ®Google Scholar
• Gavras H, Waeber B, Kershaw GR, Liang C-S, Textor SC, Brunner HR, Tifft CP, Gavras I. Role of reactive hyper-reninemia in blood pressure changes induced by sodium depletion in patients with refractory hypertension. Hypertension 1981; 3: 441
   PubMed Web of Science ®Google Scholar
• Gross F, Dietz R. The significance of volume and cardiac output in the pathogenesis of hypertension. Clin Sci 1979; 57: 59s
   PubMed Web of Science ®Google Scholar
• Haddy FJ. Mechanism, prevention and therapy of sodium-dependent hypertension. Am J Med 1980; 69: 746
   PubMed Web of Science ®Google Scholar
• Hatzinikolaou P, Gavras H, Brunner HR, Gavras I. Sodium-induced elevation of blood pressure in the anephric state. Science 1980; 209: 935
   PubMed Web of Science ®Google Scholar
• Hatzinikolaou P, Gavras H, Brunner HR, Gavras I. Role of vasopressin, catecholamines, and plasma volume in hypertonic saline-induced hypertension. Am J Physiol 1981; 240: H827
   PubMed Web of Science ®Google Scholar
• Kawasaki T, Delea CS, Bartter FC, Smith H. The effect of high sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med 1978; 64: 193
   PubMed Web of Science ®Google Scholar
• Koletsky S. Role of salt and renal mass in experimental hypertension. Arch Pathol 1959; 68: 11
   Google Scholar
• Laragh JH. Vasoconstriction-volume analysis for understanding and treating hypertension: The use of renin and aldosterone profiles. Am J Med 1973; 55: 261
   PubMed Web of Science ®Google Scholar
• Lee-Kwon WJ, Share L, Crofton JT, Shade RE, Brooks B, Muirhead EE, Manning M, Sawyer WH. Vasopressin in the rat with partial nephrectomy-salt hypertension. Clin and Exper Hypertension 1981; 3: 281
   PubMed Web of Science ®Google Scholar
• Lund-Johansen P. Hemodynamic changes in late hypertension. Hypertension in the Young and Old, G Onesti, KE Kim. Grune & Stratton, New York 1981; 239
   Google Scholar
• Man in 't Veld A, Wenting GJ, Schalekamp M ADH. Hemodynamics of early and sustained sodium-induced hypertension: consecutive measurements in man. Hypertension in the Young and Old, G Onesti, KE Kim. Grune & Stratton, New York 1981; 263
   Google Scholar
• Manning M, Lowbridge J, Stier CT, Haldar J, Sawyer WH. (1-Deaminopenicillamine, 4-valine)-8-D-arginine-vasopressin, a highly potent inhibitor of the vasopressor response to arginine vasopressin1. J Medicinal Chem 1977; 20: 1228
   PubMed Web of Science ®Google Scholar
• Melby JC, Dale SL, Wilson TE. 18-hydroxy-deoxycortico-sterone in human hypertension. Circ Res 1971; 28(Suppl 2)29, 143
   Google Scholar
• Pendleton RG, Kaiser C, Gessner G, Finlay E, Green H. Studies on SK&F7698: an inhibitor of phenylethanolamine-N-methyltransferase (PNMT). J Pharmacol Exp Ther 1974; 190: 551
   PubMed Web of Science ®Google Scholar
• Prior AM, Evans JG, Harvey H PB, Davidson F, Lindsay M. Sodium intake and blood pressure in two Polynesian populations. New Eng J Med 1968; 279: 515
   PubMed Web of Science ®Google Scholar
• Saavedra JM, Grobecker H, Axelrod J. Adrenaline-forming enzyme in brain-stem: elevation in genetic and experimental hypertension. Science 1976; 191: 483
   PubMed Web of Science ®Google Scholar
• Waeber B, Gavras H, Gavras I, Bresnahan MR, Brunner HR. Evidence for a sodium-induced activation of central neurogenic mechanisms in one-kidney, one-clip renal hypertensive rats, (Submitted for publication)
   Google Scholar